Monitoring Adverse Drug Events in Web Forums: Evaluation of a Pipeline and Use Case Study.

ABSTRACT:

Background

To mitigate safety concerns, regulatory agencies must make informed decisions regarding drug usage and adverse drug events (ADEs). The primary pharmacovigilance data stem from spontaneous reports by health care professionals. However, underreporting poses a notable challenge within the current system. Explorations into alternative sources, including electronic patient records and social media, have been undertaken. Nevertheless, social media's potential remains largely untapped in real-world scenarios.

Objective

The challenge faced by regulatory agencies in using social media is primarily attributed to the absence of suitable tools to support decision makers. An effective tool should enable access to information via a graphical user interface, presenting data in a

SUBMITTER: Karapetiantz P 

PROVIDER: S-EPMC11220433 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature